Anlotinib plus penpulimab significantly improved progression-free survival and overall survival versus sorafenib in unresectable HCC and might be a new first-line option. These findings require ...

Riley RD, Ensor J, Snell KIE, Debray TPA, Altman DG, Moons KGM, et al. External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities ...

Background Accurate pre-ablation differentiation between left (LVOT) and right (RVOT) ventricular outflow tract arrhythmias (OTVAs) using ECG algorithms is essential for decision on vascular access ...